QIM
PTLA

Quantitative Investment Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Quantitative Investment Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-198,899
Closed -$1.42M – 759
2020
Q1 		$1.42M Buy
+198,899
New +$2.48M 0.15% 159
2017
Q4 		– Sell
-14,200
Closed -$767K – 927
2017
Q3 		$767K Sell
14,200
-39,400
-74% -$2.31M 0.01% 584
2017
Q2 		$3.01M Buy
+53,600
New +$2.15M 0.05% 436

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Quantitative Investment Management's PTLA Position: Q2 2020 in Review

Quantitative Investment Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 198,899 shares — an estimated $1.42M sold.

Quantitative Investment Management first reported a position in PTLA in Q2 2017 and held it in 3 quarters. The position peaked at $3.01M in Q2 2017. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • Quantitative Investment Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Quantitative Investment Management sold 198,899 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $1.42M.
  • Quantitative Investment Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2017 and held it in 3 quarters.
  • Quantitative Investment Management's Portola Pharmaceuticals, Inc. position peaked at $3.01M in Q2 2017.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Quantitative Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.